In the last trading session, 2.52 million shares of the Phio Pharmaceuticals Corp (NASDAQ:PHIO) were traded, and its beta was 0.85. Most recently the company’s share price was $1.74, and it changed around $0.09 or 5.45% from the last close, which brings the market valuation of the company to $8.32M. PHIO currently trades at a discount to its 52-week high of $9.79, offering almost -462.64% off that amount. The share price’s 52-week low was $0.97, which indicates that the current value has risen by an impressive 44.25% since then. We note from Phio Pharmaceuticals Corp’s average daily trading volume that its 10-day average is 16.05 million shares, with the 3-month average coming to 8.62 million.
Phio Pharmaceuticals Corp stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PHIO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Phio Pharmaceuticals Corp is expected to report earnings per share of 0 for the current quarter.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Instantly PHIO has showed a green trend with a performance of 5.45% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.7300 on recent trading dayincreased the stock’s daily price by 36.26%. The company’s shares are currently down -3.33% year-to-date, but still up 62.62% over the last five days. On the other hand, Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 30.83% up in the 30-day period. We can see from the shorts that 78709.0 shares have been sold at a short interest cover period of 0.77 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 66.30%.
PHIO Dividends
Phio Pharmaceuticals Corp’s next quarterly earnings report is expected to be released on 2025-Mar-30.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.29% of Phio Pharmaceuticals Corp shares, and 16.95% of them are in the hands of institutional investors. The stock currently has a share float of 17.00%.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 4.24 shares worth $7384.0, making up 0.09% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 2.71 shares worth around $4710.0, which represents about 0.06% of the total shares outstanding.
